speb/financial-data huggingface dataset:
CHAMBLFERT.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 26200700000.00
CHAMBLFERT.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 40125500000.00
CHAMBLFERT.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 40125500000.00
CHAMBLFERT.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 84403000000.00
CHAMBLFERT.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 84403000000.00
CHAMBLFERT.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14572500000.00
CHAMBLFERT.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14572500000.00
CHAMBLFERT.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 206900000.00
CHAMBLFERT.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 206900000.00
CHAMBLFERT.NS balance_sheet (annual, 2026-03-31) — Working Capital: 34068400000.00
CHAMBLFERT.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 34068400000.00
CHAR income_statement (quarterly, 2024-09-30) — +Operating Expense: 315671.00
CHAR income_statement (quarterly, 2024-09-30) — +Total Revenue: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 210129.00
CHAR income_statement (quarterly, 2024-09-30) — Basic Average Shares: 1875000.00
CHAR income_statement (quarterly, 2024-09-30) — Basic EPS: -0.17
CHAR cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Capital Stock: 216.00
CHAR cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: 0.00
CHAR cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 0.00
CHAR cash_flow (quarterly, 2024-09-30) — Change In Payable: 25000.00
CHAR cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: 25000.00
CHAR cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: 0.00
CHAR cash_flow (quarterly, 2024-09-30) — Change In Working Capital: 25000.00
CHAR balance_sheet (quarterly, 2024-09-30) — Common Stock: 216.00
CHAR balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: -121179.00
CHAR balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 33459.00
CHAR balance_sheet (quarterly, 2024-09-30) — Current Assets: 10000.00
CHAR balance_sheet (quarterly, 2024-09-30) — Current Debt: 268723.00
CHAR balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 268723.00
CHAR balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 330932.00
CHAR income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 1875000.00
CHAR income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.17
CHAR income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: -315671.00
CHAR balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 28750.00
CHAR income_statement (quarterly, 2024-09-30) — EBIT: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — EBITDA: -315671.00
CHAR cash_flow (quarterly, 2024-09-30) — End Cash Position: 0.00
CHAR cash_flow (quarterly, 2024-09-30) — Free Cash Flow: 0.00
CHAR income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 185345.00
CHAR income_statement (quarterly, 2024-09-30) — Interest Income: 0.00
CHAR income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Invested Capital: 147544.00
CHAR balance_sheet (quarterly, 2024-09-30) — Net Debt: 268723.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -315671.00
CHAR cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Net Interest Income: 0.00
CHAR income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: -121179.00
CHAR balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 199753.00
CHAR income_statement (quarterly, 2024-09-30) — Normalized EBITDA: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Normalized Income: -315671.00
CHAR cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: 0.00
CHAR income_statement (quarterly, 2024-09-30) — Operating Income: -315671.00
CHAR income_statement (quarterly, 2024-09-30) — Operating Revenue: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 1875000.00
CHAR balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 268723.00
CHAR cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 105326.00
CHAR income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 130326.00
CHAR balance_sheet (quarterly, 2024-09-30) — Payables: 28750.00
CHAR balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 62209.00
CHAR balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 10000.00
CHAR income_statement (quarterly, 2024-09-30) — Pretax Income: -315671.00
CHAR balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -331524.00
CHAR income_statement (quarterly, 2024-09-30) — Salaries And Wages: 185345.00
CHAR income_statement (quarterly, 2024-09-30) — Selling General And Administration: 185345.00
CHAR balance_sheet (quarterly, 2024-09-30) — Share Issued: 1875000.00
CHAR balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: -121179.00
CHAR balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: -121179.00
CHAR income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Assets: 209753.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Capitalization: -121179.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Debt: 268723.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: -121179.00
CHAR income_statement (quarterly, 2024-09-30) — Total Expenses: 315671.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 330932.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 199753.00
CHAR balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CHAR income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -315671.00
CHAR balance_sheet (quarterly, 2024-09-30) — Working Capital: -320932.00
CHAR income_statement (quarterly, 2024-12-31) — +Operating Expense: 259769.00
CHAR income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
CHAR balance_sheet (annual, 2024-12-31) — Accounts Payable: 35884.00
CHAR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 0.00
CHAR cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 0.00
CHAR balance_sheet (annual, 2024-12-31) — Capital Stock: 85870371.00
CHAR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 447419.00
CHAR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 447419.00
CHAR balance_sheet (annual, 2024-12-31) — Cash Financial: 447419.00
CHAR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -171290.00
CHAR cash_flow (quarterly, 2024-12-31) — Change In Payable: 20884.00
CHAR cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 20884.00
CHAR cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 11519.00
CHAR balance_sheet (annual, 2024-12-31) — Common Stock: 85870371.00
CHAR balance_sheet (annual, 2024-12-31) — Common Stock Equity: 84577274.00
CHAR balance_sheet (annual, 2024-12-31) — Current Assets: 456784.00
CHAR balance_sheet (annual, 2024-12-31) — Current Liabilities: 49634.00
CHAR income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 598362.00
CHAR balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 13750.00
CHAR income_statement (quarterly, 2024-12-31) — EBIT: -259769.00
CHAR income_statement (quarterly, 2024-12-31) — EBITDA: -259769.00
CHAR cash_flow (quarterly, 2024-12-31) — End Cash Position: 447419.00
CHAR cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -171290.00
CHAR income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 64350.00
CHAR balance_sheet (annual, 2024-12-31) — Invested Capital: 84577274.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income: 598362.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 598362.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 598362.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 598362.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 598362.00
CHAR cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 598362.00
CHAR income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 598362.00
CHAR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 84577274.00
CHAR income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -259769.00
CHAR income_statement (quarterly, 2024-12-31) — Normalized Income: 598362.00
CHAR cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -171290.00
CHAR income_statement (quarterly, 2024-12-31) — Operating Income: -259769.00
CHAR income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
CHAR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 10965000.00
CHAR cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -187897.00
CHAR balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 85870124.00
CHAR income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 195419.00
CHAR balance_sheet (annual, 2024-12-31) — Payables: 49634.00
CHAR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 49634.00
CHAR balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CHAR balance_sheet (annual, 2024-12-31) — Prepaid Assets: 9365.00
CHAR income_statement (quarterly, 2024-12-31) — Pretax Income: 598362.00
CHAR balance_sheet (annual, 2024-12-31) — Retained Earnings: -1293097.00
CHAR income_statement (quarterly, 2024-12-31) — Salaries And Wages: 64350.00
CHAR income_statement (quarterly, 2024-12-31) — Selling General And Administration: 64350.00
CHAR balance_sheet (annual, 2024-12-31) — Share Issued: 10965000.00
CHAR cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 64350.00
CHAR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 84577274.00
CHAR balance_sheet (annual, 2024-12-31) — Tangible Book Value: 84577274.00
CHAR income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
CHAR balance_sheet (annual, 2024-12-31) — Total Assets: 86326908.00
CHAR balance_sheet (annual, 2024-12-31) — Total Capitalization: 84577274.00
CHAR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 84577274.00
CHAR income_statement (quarterly, 2024-12-31) — Total Expenses: 259769.00
CHAR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1749634.00
CHAR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 85870124.00
CHAR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (annual, 2024-12-31) — Working Capital: 407150.00
CHAR income_statement (quarterly, 2025-03-31) — +Operating Expense: 170252.00
CHAR income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 38562.00
CHAR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
CHAR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-03-31) — Basic EPS: 0.07
CHAR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 447419.00
CHAR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 86769573.00
CHAR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 186232.00
CHAR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 186232.00
CHAR balance_sheet (quarterly, 2025-03-31) — Cash Financial: 186232.00
CHAR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CHAR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -261187.00
CHAR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2678.00
CHAR cash_flow (quarterly, 2025-03-31) — Change In Payable: 2678.00
CHAR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2678.00
CHAR cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -95920.00
CHAR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -93242.00
CHAR cash_flow (quarterly, 2025-03-31) — Changes In Cash: -261187.00
CHAR balance_sheet (quarterly, 2025-03-31) — Common Stock: 86769573.00
CHAR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 85308531.00
CHAR balance_sheet (quarterly, 2025-03-31) — Current Assets: 291517.00
CHAR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 52312.00
CHAR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.07
CHAR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 731257.00
CHAR balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 13750.00
CHAR income_statement (quarterly, 2025-03-31) — EBIT: -170252.00
CHAR income_statement (quarterly, 2025-03-31) — EBITDA: -170252.00
CHAR cash_flow (quarterly, 2025-03-31) — End Cash Position: 186232.00
CHAR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CHAR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -261187.00
CHAR income_statement (quarterly, 2025-03-31) — Interest Income: 901509.00
CHAR income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 901509.00
CHAR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 85308531.00
CHAR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 731257.00
CHAR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 731257.00
CHAR income_statement (quarterly, 2025-03-31) — Net Interest Income: 901509.00
CHAR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CHAR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 901509.00
CHAR cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
CHAR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 85308531.00
CHAR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -170252.00
CHAR income_statement (quarterly, 2025-03-31) — Normalized Income: 731257.00
CHAR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -261187.00
CHAR income_statement (quarterly, 2025-03-31) — Operating Income: -170252.00
CHAR income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 10965000.00
CHAR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -899202.00
CHAR balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 86769326.00
CHAR income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 170252.00
CHAR balance_sheet (quarterly, 2025-03-31) — Payables: 52312.00
CHAR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 52312.00
CHAR balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 105285.00
CHAR income_statement (quarterly, 2025-03-31) — Pretax Income: 731257.00
CHAR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1461042.00
CHAR balance_sheet (quarterly, 2025-03-31) — Share Issued: 10965000.00
CHAR cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
CHAR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 85308531.00
CHAR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 85308531.00
CHAR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CHAR balance_sheet (quarterly, 2025-03-31) — Total Assets: 87060843.00
CHAR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 85308531.00
CHAR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 85308531.00
CHAR income_statement (quarterly, 2025-03-31) — Total Expenses: 170252.00
CHAR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1752312.00
CHAR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 86769326.00
CHAR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -170252.00
CHAR balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (quarterly, 2025-03-31) — Working Capital: 239205.00
CHAR income_statement (quarterly, 2025-06-30) — +Operating Expense: 127380.00
CHAR income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4692.00
CHAR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 0.00
CHAR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
CHAR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 186232.00
CHAR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 87674201.00
CHAR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 48631.00
CHAR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 48631.00
CHAR balance_sheet (quarterly, 2025-06-30) — Cash Financial: 48631.00
CHAR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -137601.00
CHAR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -33870.00
CHAR cash_flow (quarterly, 2025-06-30) — Change In Payable: -46370.00
CHAR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -46370.00
CHAR cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 35373.00
CHAR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -10997.00
CHAR cash_flow (quarterly, 2025-06-30) — Changes In Cash: -137601.00
CHAR balance_sheet (quarterly, 2025-06-30) — Common Stock: 87674201.00
CHAR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 86086555.00
CHAR balance_sheet (quarterly, 2025-06-30) — Current Assets: 118543.00
CHAR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5942.00
CHAR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
CHAR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 778024.00
CHAR balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 1250.00
CHAR income_statement (quarterly, 2025-06-30) — EBIT: -127380.00
CHAR income_statement (quarterly, 2025-06-30) — EBITDA: -127380.00
CHAR cash_flow (quarterly, 2025-06-30) — End Cash Position: 48631.00
CHAR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -137601.00
CHAR income_statement (quarterly, 2025-06-30) — Interest Income: 905404.00
CHAR income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 905404.00
CHAR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 86086555.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 778024.00
CHAR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 778024.00
CHAR income_statement (quarterly, 2025-06-30) — Net Interest Income: 905404.00
CHAR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 905404.00
CHAR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 86086555.00
CHAR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -127380.00
CHAR income_statement (quarterly, 2025-06-30) — Normalized Income: 778024.00
CHAR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -137601.00
CHAR income_statement (quarterly, 2025-06-30) — Operating Income: -127380.00
CHAR income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 10965000.00
CHAR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -904628.00
CHAR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 87673954.00
CHAR income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 127380.00
CHAR balance_sheet (quarterly, 2025-06-30) — Payables: 5942.00
CHAR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5942.00
CHAR balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 69912.00
CHAR income_statement (quarterly, 2025-06-30) — Pretax Income: 778024.00
CHAR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1587646.00
CHAR balance_sheet (quarterly, 2025-06-30) — Share Issued: 10965000.00
CHAR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 86086555.00
CHAR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 86086555.00
CHAR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CHAR balance_sheet (quarterly, 2025-06-30) — Total Assets: 87792497.00
CHAR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 86086555.00
CHAR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 86086555.00
CHAR income_statement (quarterly, 2025-06-30) — Total Expenses: 127380.00
CHAR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1705942.00
CHAR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 87673954.00
CHAR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -127380.00
CHAR balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (quarterly, 2025-06-30) — Working Capital: 112601.00
CHAR income_statement (quarterly, 2025-09-30) — +Operating Expense: 109077.00
CHAR income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18112.00
CHAR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
CHAR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-09-30) — Basic EPS: 0.07
CHAR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 48631.00
CHAR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 88590173.00
CHAR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10775.00
CHAR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10775.00
CHAR balance_sheet (quarterly, 2025-09-30) — Cash Financial: 10775.00
CHAR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -37856.00
CHAR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 13420.00
CHAR cash_flow (quarterly, 2025-09-30) — Change In Payable: 38420.00
CHAR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 38420.00
CHAR cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 32707.00
CHAR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 71127.00
CHAR cash_flow (quarterly, 2025-09-30) — Changes In Cash: -37856.00
CHAR balance_sheet (quarterly, 2025-09-30) — Common Stock: 88590173.00
CHAR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 86893544.00
CHAR balance_sheet (quarterly, 2025-09-30) — Current Assets: 47980.00
CHAR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 44362.00
CHAR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 10965000.00
CHAR income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.07
CHAR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 806989.00
CHAR balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 26250.00
CHAR income_statement (quarterly, 2025-09-30) — EBIT: -109077.00
CHAR income_statement (quarterly, 2025-09-30) — EBITDA: -109077.00
CHAR cash_flow (quarterly, 2025-09-30) — End Cash Position: 10775.00
CHAR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -37856.00
CHAR income_statement (quarterly, 2025-09-30) — Interest Income: 916066.00
CHAR income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 916066.00
CHAR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 86893544.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 806989.00
CHAR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 806989.00
CHAR income_statement (quarterly, 2025-09-30) — Net Interest Income: 916066.00
CHAR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 916066.00
CHAR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 86893544.00
CHAR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -109077.00
CHAR income_statement (quarterly, 2025-09-30) — Normalized Income: 806989.00
CHAR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -37856.00
CHAR income_statement (quarterly, 2025-09-30) — Operating Income: -109077.00
CHAR income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CHAR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 10965000.00
CHAR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -915972.00
CHAR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 88589926.00
CHAR income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 109077.00
CHAR balance_sheet (quarterly, 2025-09-30) — Payables: 44362.00
CHAR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 44362.00
CHAR balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 37205.00
CHAR income_statement (quarterly, 2025-09-30) — Pretax Income: 806989.00
CHAR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1696629.00
CHAR income_statement (quarterly, 2025-09-30) — Salaries And Wages: 0.00
CHAR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 0.00
CHAR balance_sheet (quarterly, 2025-09-30) — Share Issued: 10965000.00
CHAR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 86893544.00
CHAR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 86893544.00
CHAR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CHAR balance_sheet (quarterly, 2025-09-30) — Total Assets: 88637906.00
CHAR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 86893544.00
CHAR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 86893544.00
CHAR income_statement (quarterly, 2025-09-30) — Total Expenses: 109077.00
CHAR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1744362.00
CHAR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 88589926.00
CHAR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -109077.00
CHAR balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (quarterly, 2025-09-30) — Working Capital: 3618.00
CHAR income_statement (annual, 2025-12-31) — +Operating Expense: 595545.00
CHAR income_statement (quarterly, 2025-12-31) — +Operating Expense: 188836.00
CHAR income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CHAR income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Accounts Payable: 33877.00
CHAR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 33877.00
CHAR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
CHAR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
CHAR income_statement (annual, 2025-12-31) — Basic Average Shares: 10965000.00
CHAR income_statement (annual, 2025-12-31) — Basic EPS: 0.27
CHAR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 447419.00
CHAR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 10775.00
CHAR balance_sheet (annual, 2025-12-31) — Capital Stock: 89444780.00
CHAR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 89444780.00
CHAR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5135.00
CHAR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5135.00
CHAR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5135.00
CHAR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5135.00
CHAR balance_sheet (annual, 2025-12-31) — Cash Financial: 5135.00
CHAR balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5135.00
CHAR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 100881.00
CHAR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CHAR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -543165.00
CHAR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -106521.00
CHAR cash_flow (annual, 2025-12-31) — Change In Account Payable: -2007.00
CHAR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 15765.00
CHAR cash_flow (annual, 2025-12-31) — Change In Payable: 47993.00
CHAR cash_flow (quarterly, 2025-12-31) — Change In Payable: 53265.00
CHAR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 47993.00
CHAR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 53265.00
CHAR cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1209.00
CHAR cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 29049.00
CHAR cash_flow (annual, 2025-12-31) — Change In Working Capital: 49202.00
CHAR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 82314.00
CHAR cash_flow (annual, 2025-12-31) — Changes In Cash: -442284.00
CHAR cash_flow (quarterly, 2025-12-31) — Changes In Cash: -5640.00
CHAR balance_sheet (annual, 2025-12-31) — Common Stock: 89444780.00
CHAR balance_sheet (quarterly, 2025-12-31) — Common Stock: 89444780.00
CHAR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 87559316.00
CHAR cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Current Assets: 13291.00
CHAR balance_sheet (quarterly, 2025-12-31) — Current Assets: 13291.00
CHAR balance_sheet (annual, 2025-12-31) — Current Debt: 100881.00
CHAR balance_sheet (quarterly, 2025-12-31) — Current Debt: 100881.00
CHAR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 100881.00
CHAR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 100881.00
CHAR balance_sheet (annual, 2025-12-31) — Current Liabilities: 198508.00
CHAR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 198508.00
CHAR income_statement (annual, 2025-12-31) — Diluted Average Shares: 10965000.00
CHAR income_statement (annual, 2025-12-31) — Diluted EPS: 0.27
CHAR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 665772.00
CHAR balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 63750.00
CHAR balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 63750.00
CHAR income_statement (annual, 2025-12-31) — EBIT: -595545.00
CHAR income_statement (quarterly, 2025-12-31) — EBIT: -188836.00
CHAR income_statement (annual, 2025-12-31) — EBITDA: -595545.00
CHAR income_statement (quarterly, 2025-12-31) — EBITDA: -188836.00
CHAR cash_flow (annual, 2025-12-31) — End Cash Position: 5135.00
CHAR cash_flow (quarterly, 2025-12-31) — End Cash Position: 5135.00
CHAR cash_flow (annual, 2025-12-31) — Financing Cash Flow: 100881.00
CHAR cash_flow (annual, 2025-12-31) — Free Cash Flow: -543165.00
CHAR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -106521.00
CHAR cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -3574409.00
CHAR income_statement (annual, 2025-12-31) — Interest Income: 3577587.00
CHAR income_statement (quarterly, 2025-12-31) — Interest Income: 854608.00
CHAR income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3577587.00
CHAR income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 854608.00
CHAR balance_sheet (annual, 2025-12-31) — Invested Capital: 87660197.00
CHAR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 87660197.00
CHAR cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
CHAR cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CHAR cash_flow (annual, 2025-12-31) — Issuance Of Debt: 100881.00
CHAR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Net Debt: 95746.00
CHAR balance_sheet (quarterly, 2025-12-31) — Net Debt: 95746.00
CHAR income_statement (annual, 2025-12-31) — Net Income: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 665772.00
CHAR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2982042.00
CHAR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 665772.00
CHAR income_statement (annual, 2025-12-31) — Net Interest Income: 3577587.00
CHAR income_statement (quarterly, 2025-12-31) — Net Interest Income: 854608.00
CHAR cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 100881.00
CHAR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3577587.00
CHAR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 854608.00
CHAR cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 100881.00
CHAR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 87559316.00
CHAR income_statement (annual, 2025-12-31) — Normalized EBITDA: -595545.00
CHAR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -188836.00
CHAR income_statement (annual, 2025-12-31) — Normalized Income: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Normalized Income: 665772.00
CHAR cash_flow (annual, 2025-12-31) — Operating Cash Flow: -543165.00
CHAR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -106521.00
CHAR cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3574409.00
CHAR income_statement (annual, 2025-12-31) — Operating Income: -595545.00
CHAR income_statement (quarterly, 2025-12-31) — Operating Income: -188836.00
CHAR income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CHAR income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10965000.00
CHAR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 10965000.00
CHAR balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 100881.00
CHAR balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 100881.00
CHAR balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 89444533.00
CHAR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 89444533.00
CHAR income_statement (annual, 2025-12-31) — Other Operating Expenses: 595545.00
CHAR income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 188836.00
CHAR balance_sheet (annual, 2025-12-31) — Payables: 97627.00
CHAR balance_sheet (quarterly, 2025-12-31) — Payables: 97627.00
CHAR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 97627.00
CHAR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 97627.00
CHAR balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8156.00
CHAR balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 8156.00
CHAR income_statement (annual, 2025-12-31) — Pretax Income: 2982042.00
CHAR income_statement (quarterly, 2025-12-31) — Pretax Income: 665772.00
CHAR cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Retained Earnings: -1885464.00
CHAR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1885464.00
CHAR income_statement (annual, 2025-12-31) — Salaries And Wages: 0.00
CHAR income_statement (quarterly, 2025-12-31) — Salaries And Wages: 0.00
CHAR income_statement (annual, 2025-12-31) — Selling General And Administration: 0.00
CHAR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Share Issued: 10965000.00
CHAR balance_sheet (quarterly, 2025-12-31) — Share Issued: 10965000.00
CHAR cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 100881.00
CHAR cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
CHAR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
CHAR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
CHAR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 87559316.00
CHAR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 87559316.00
CHAR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHAR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CHAR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CHAR balance_sheet (annual, 2025-12-31) — Total Assets: 89457824.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Assets: 89457824.00
CHAR balance_sheet (annual, 2025-12-31) — Total Capitalization: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 87559316.00
CHAR balance_sheet (annual, 2025-12-31) — Total Debt: 100881.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Debt: 100881.00
CHAR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 87559316.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 87559316.00
CHAR income_statement (annual, 2025-12-31) — Total Expenses: 595545.00
CHAR income_statement (quarterly, 2025-12-31) — Total Expenses: 188836.00
CHAR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1898508.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1898508.00
CHAR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 89444533.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 89444533.00
CHAR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1700000.00
CHAR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -595545.00
CHAR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -188836.00
CHAR balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 1700000.00
CHAR balance_sheet (annual, 2025-12-31) — Working Capital: -185217.00
CHAR balance_sheet (quarterly, 2025-12-31) — Working Capital: -185217.00
CHAR income_statement (quarterly, 2026-03-31) — +Operating Expense: 86609.00
CHAR income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CHAR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 139792.00
CHAR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
CHAR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 10965000.00
CHAR income_statement (quarterly, 2026-03-31) — Basic EPS: 0.06
CHAR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5135.00
CHAR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 90231260.00
CHAR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4597.00
CHAR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4597.00
CHAR balance_sheet (quarterly, 2026-03-31) — Cash Financial: 4597.00
CHAR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 42000.00
CHAR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -42538.00
CHAR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 105915.00
CHAR cash_flow (quarterly, 2026-03-31) — Change In Payable: 43375.00
CHAR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 43375.00
CHAR cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 695.00
CHAR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 44070.00
CHAR cash_flow (quarterly, 2026-03-31) — Changes In Cash: -538.00
CHAR balance_sheet (quarterly, 2026-03-31) — Common Stock: 90231260.00
CHAR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 88259188.00
CHAR balance_sheet (quarterly, 2026-03-31) — Current Assets: 12058.00
CHAR balance_sheet (quarterly, 2026-03-31) — Current Debt: 142881.00
CHAR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 142881.00
CHAR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 283883.00
CHAR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 10965000.00
CHAR income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.06
CHAR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 699872.00
CHAR balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 1210.00
CHAR income_statement (quarterly, 2026-03-31) — EBIT: -86609.00
CHAR income_statement (quarterly, 2026-03-31) — EBITDA: -86609.00
CHAR cash_flow (quarterly, 2026-03-31) — End Cash Position: 4597.00
CHAR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 42000.00
CHAR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -42538.00
CHAR income_statement (quarterly, 2026-03-31) — Interest Income: 786481.00
CHAR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 786481.00
CHAR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 88402069.00
CHAR cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 42000.00
CHAR balance_sheet (quarterly, 2026-03-31) — Net Debt: 138284.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 699872.00
CHAR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 699872.00
CHAR income_statement (quarterly, 2026-03-31) — Net Interest Income: 786481.00
CHAR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 42000.00
CHAR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 786481.00
CHAR cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 42000.00
CHAR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 88259188.00
CHAR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -86609.00
CHAR income_statement (quarterly, 2026-03-31) — Normalized Income: 699872.00
CHAR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -42538.00
CHAR income_statement (quarterly, 2026-03-31) — Operating Income: -86609.00
CHAR income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CHAR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 10965000.00
CHAR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 142881.00
CHAR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -786480.00
CHAR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 90231013.00
CHAR income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 86609.00
CHAR balance_sheet (quarterly, 2026-03-31) — Payables: 141002.00
CHAR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 141002.00
CHAR balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHAR balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 7461.00
CHAR income_statement (quarterly, 2026-03-31) — Pretax Income: 699872.00